Clinical Trial Update: Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating ACTH Gel (ACTHAR) for treatment-resistant nephrotic syndrome; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• ACTH Gel (ACTHAR) (adrenocorticotropic hormone)

Snippet

Sponsor: Columbia University | Conditions: Treatment Resistant Nephrotic Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2014-04-24